echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Osaikang's "Injection of sodium palladium" was the first review

    Osaikang's "Injection of sodium palladium" was the first review

    • Last Update: 2020-11-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On November 2, NMPA's official website showed that Jiangsu Osaikang had passed a consistent evaluation of "injection of sodium palladium", the first evaluation of the variety.
    the first batch of Sodium Esomeprazole, which also ushered in the first review, belongs to proton pump inhibitors (PPI), mainly by inhibiting the secretion of H-plus driven by proton pumps in the stomach wall cells, thereby inhibiting the secretion of stomach acid.
    The main dosage forms of pyroazole currently listed for sale in China are injections, intestinal tablets and intestinal capsules, of which injections are the most widely used clinically, and public data show that sales of end-use pyroazole in public medical institutions in China in 2019 amounted to RMB8,907 million, down 9.37% YoY.
    Insight database shows that 16 companies have submitted supplementary applications (including Jiangsu Osaikang) for sodium in injections, and 2 companies have submitted applications for listing under the new registration classification, involving a total of 32 product regulations.
    , Osaikang was the first company to submit a supplementary application, and the first to pass a consistency review.
    from: Insight Database () Currently there are six proton pump inhibitors in the domestic market, Lansolazole, pythola, omeprazole, Esomeprazole and Epprazole, all available in injection and oral dosage forms.
    , however, according to Insight data, all but esomeprazole and vitolazole in this review were not evaluated with injections.
    the two PPI reviews with a consistent evaluation, which kicks off the PPI review.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.